His lab is engaged on refining the alanine-scanning assay to a few important residues that could correctly distinguish between fibrils from neurodegenerative tauopathies. He envisions applying this streamlined assay for postmortem neuropathological prognosis, And maybe for blood screening of tauopathies.Quite a few colleagues have built the counter